Selected research
Industry Growth & Trends
Global Genetically Modified Animal Models Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Genetically Modified Animal Models market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Genetically Modified Animal Models is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Genetically Modified Animal Models market include ModelOrg, GemPharmatech, Cyagen Biosciences, Biocytogen, JOINN, China Environmental Technology and Bioenergy, Charles River, Taconic Biosciences and GenOway, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Genetically Modified Animal Models market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Genetically Modified Animal Models market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genetically Modified Animal Models market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genetically Modified Animal Models.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Genetically Modified Animal Models market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Genetically Modified Animal Models Market by Company
ModelOrg
GemPharmatech
Cyagen Biosciences
Biocytogen
JOINN
China Environmental Technology and Bioenergy
Charles River
Taconic Biosciences
GenOway
CLEA Japan
Ozgene
InVivo Biosystems
Harbour BioMed
PolyGene
Genetically Modified Animal Models Segment by Type
Rodents
Non-Human Primates
Zebrafish
Others
Genetically Modified Animal Models Segment by Application
Universities
Hospitals
Pharmaceutical Companies
Others
Genetically Modified Animal Models Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Animal Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Animal Models and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Animal Models.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Genetically Modified Animal Models companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Rodents
- Non-Human Primates
- Zebrafish
- Others
Applications
- Universities
- Hospitals
- Pharmaceutical Companies
- Others
Companies covered
- ModelOrg
- GemPharmatech
- Cyagen Biosciences
- Biocytogen
- JOINN
- China Environmental Technology and Bioenergy
- Charles River
- Taconic Biosciences
- GenOway
- CLEA Japan
- Ozgene
- InVivo Biosystems
- Harbour BioMed
- PolyGene
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Genetically Modified Animal Models Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Genetically Modified Animal Models Market Size by Region (2021-2032)
- 1.4.1 Global Genetically Modified Animal Models Market Size by Region (2021-2026)
- 1.4.2 Global Genetically Modified Animal Models Market Size by Region (2027-2032)
- 1.5 Key Regions Genetically Modified Animal Models Market Size (2021-2032)
- 1.5.1 North America Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
- 1.5.4 South America Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Genetically Modified Animal Models Market Size Growth Rate (2021-2032)
2 Genetically Modified Animal Models Market by Type
- 2.1 Type Introduction
- 2.1.1 Rodents
- 2.1.2 Non-Human Primates
- 2.1.3 Zebrafish
- 2.1.4 Others
- 2.2 Global Genetically Modified Animal Models Market Size by Type
- 2.2.1 Global Genetically Modified Animal Models Market Size Overview by Type (2021-2032)
- 2.2.2 Global Genetically Modified Animal Models Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Genetically Modified Animal Models Market Size Forecasted by Type (2027-2032)
- 2.3 Global Genetically Modified Animal Models Market Size by Regions
- 2.3.1 North America Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Genetically Modified Animal Models Market Size Breakdown by Type (2021-2026)
3 Genetically Modified Animal Models Market by Application
- 3.1 Type Introduction
- 3.1.1 Universities
- 3.1.2 Hospitals
- 3.1.3 Pharmaceutical Companies
- 3.1.4 Others
- 3.2 Global Genetically Modified Animal Models Market Size by Application
- 3.2.1 Global Genetically Modified Animal Models Market Size Overview by Application (2021-2032)
- 3.2.2 Global Genetically Modified Animal Models Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Genetically Modified Animal Models Market Size Forecasted by Application (2027-2032)
- 3.3 Global Genetically Modified Animal Models Market Size by Regions
- 3.3.1 North America Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Genetically Modified Animal Models Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Genetically Modified Animal Models Industry Trends
- 4.2 Genetically Modified Animal Models Industry Drivers
- 4.3 Genetically Modified Animal Models Industry Opportunities and Challenges
- 4.4 Genetically Modified Animal Models Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Genetically Modified Animal Models Revenue (2021-2026)
- 5.2 Global Genetically Modified Animal Models Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Genetically Modified Animal Models Key Company Headquarters & Area Served
- 5.4 Global Genetically Modified Animal Models Company, Product Type & Application
- 5.5 Global Genetically Modified Animal Models Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Genetically Modified Animal Models Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Genetically Modified Animal Models Players Market Share by Revenue in 2025
- 5.6.3 2025 Genetically Modified Animal Models Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 ModelOrg
- 6.1.1 ModelOrg Company Information
- 6.1.2 ModelOrg Business Overview
- 6.1.3 ModelOrg Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 ModelOrg Genetically Modified Animal Models Product Portfolio
- 6.1.5 ModelOrg Recent Developments
- 6.2 GemPharmatech
- 6.2.1 GemPharmatech Company Information
- 6.2.2 GemPharmatech Business Overview
- 6.2.3 GemPharmatech Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 GemPharmatech Genetically Modified Animal Models Product Portfolio
- 6.2.5 GemPharmatech Recent Developments
- 6.3 Cyagen Biosciences
- 6.3.1 Cyagen Biosciences Company Information
- 6.3.2 Cyagen Biosciences Business Overview
- 6.3.3 Cyagen Biosciences Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Cyagen Biosciences Genetically Modified Animal Models Product Portfolio
- 6.3.5 Cyagen Biosciences Recent Developments
- 6.4 Biocytogen
- 6.4.1 Biocytogen Company Information
- 6.4.2 Biocytogen Business Overview
- 6.4.3 Biocytogen Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Biocytogen Genetically Modified Animal Models Product Portfolio
- 6.4.5 Biocytogen Recent Developments
- 6.5 JOINN
- 6.5.1 JOINN Company Information
- 6.5.2 JOINN Business Overview
- 6.5.3 JOINN Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 JOINN Genetically Modified Animal Models Product Portfolio
- 6.5.5 JOINN Recent Developments
- 6.6 China Environmental Technology and Bioenergy
- 6.6.1 China Environmental Technology and Bioenergy Company Information
- 6.6.2 China Environmental Technology and Bioenergy Business Overview
- 6.6.3 China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio
- 6.6.5 China Environmental Technology and Bioenergy Recent Developments
- 6.7 Charles River
- 6.7.1 Charles River Company Information
- 6.7.2 Charles River Business Overview
- 6.7.3 Charles River Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Charles River Genetically Modified Animal Models Product Portfolio
- 6.7.5 Charles River Recent Developments
- 6.8 Taconic Biosciences
- 6.8.1 Taconic Biosciences Company Information
- 6.8.2 Taconic Biosciences Business Overview
- 6.8.3 Taconic Biosciences Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Taconic Biosciences Genetically Modified Animal Models Product Portfolio
- 6.8.5 Taconic Biosciences Recent Developments
- 6.9 GenOway
- 6.9.1 GenOway Company Information
- 6.9.2 GenOway Business Overview
- 6.9.3 GenOway Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 GenOway Genetically Modified Animal Models Product Portfolio
- 6.9.5 GenOway Recent Developments
- 6.10 CLEA Japan
- 6.10.1 CLEA Japan Company Information
- 6.10.2 CLEA Japan Business Overview
- 6.10.3 CLEA Japan Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 CLEA Japan Genetically Modified Animal Models Product Portfolio
- 6.10.5 CLEA Japan Recent Developments
- 6.11 Ozgene
- 6.11.1 Ozgene Company Information
- 6.11.2 Ozgene Business Overview
- 6.11.3 Ozgene Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Ozgene Genetically Modified Animal Models Product Portfolio
- 6.11.5 Ozgene Recent Developments
- 6.12 InVivo Biosystems
- 6.12.1 InVivo Biosystems Company Information
- 6.12.2 InVivo Biosystems Business Overview
- 6.12.3 InVivo Biosystems Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 InVivo Biosystems Genetically Modified Animal Models Product Portfolio
- 6.12.5 InVivo Biosystems Recent Developments
- 6.13 Harbour BioMed
- 6.13.1 Harbour BioMed Company Information
- 6.13.2 Harbour BioMed Business Overview
- 6.13.3 Harbour BioMed Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Harbour BioMed Genetically Modified Animal Models Product Portfolio
- 6.13.5 Harbour BioMed Recent Developments
- 6.14 PolyGene
- 6.14.1 PolyGene Company Information
- 6.14.2 PolyGene Business Overview
- 6.14.3 PolyGene Genetically Modified Animal Models Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 PolyGene Genetically Modified Animal Models Product Portfolio
- 6.14.5 PolyGene Recent Developments
7 North America
- 7.1 North America Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Genetically Modified Animal Models Market Size by Country (2021-2026)
- 7.3 North America Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Genetically Modified Animal Models Market Size by Country (2021-2026)
- 8.3 Europe Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Genetically Modified Animal Models Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Genetically Modified Animal Models Market Size by Country (2021-2026)
- 10.3 South America Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Genetically Modified Animal Models Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Genetically Modified Animal Models Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst